FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2185084103> ?p ?o ?g. }

• W2185084103 endingPage "72" @default.
• W2185084103 startingPage "66" @default.
• W2185084103 abstract "People who inject drugs (PWID) are at risk of hepatitis B virus (HBV) but have low rates of vaccination completion. The provision of modest financial incentives increases vaccination schedule completion, but their association with serological protection has yet to be determined. To investigate factors associated with vaccine-induced immunity among a sample of PWID randomly allocated to receive AUD$30 cash following receipt of doses two and three (‘incentive condition’) or standard care (‘control condition’) using an accelerated 3-dose (0,7,21 days) HBV vaccination schedule. A randomised controlled trial among PWID attending two inner-city health services and a field site in Sydney, Australia, assessing vaccine-induced immunity measured by hepatitis B surface antibodies (HBsAb ≥ 10 mIU/ml) at 12 weeks. The cost of the financial incentives and the provision of the vaccine program are also reported. Just over three-quarters of participants – 107/139 (77%) – completed the vaccination schedule and 79/139 (57%) were HBsAb ≥ 10 mIU/ml at 12 weeks. Vaccine series completion was the only variable significantly associated with vaccine-induced immunity in univariate analysis (62% vs 41%, p < 0.035) but was not significant in multivariate analysis. There was no statistically discernible association between group allocation and series completion (62% vs 53%). The mean costs were AUD$150.5, (95% confidence interval [CI]: 142.7–158.3) and AUD$76.9 (95% CI: 72.6–81.3) for the intervention and control groups respectively. Despite increasing HBV vaccination completion, provision of financial incentives was not associated with enhanced serological protection. Further research into factors which affect response rates and the optimal vaccination regimen and incentive schemes for this population are needed." @default.
• W2185084103 created "2016-06-24" @default.
• W2185084103 creator A5008151489 @default.
• W2185084103 creator A5010104290 @default.
• W2185084103 creator A5018606311 @default.
• W2185084103 creator A5022216009 @default.
• W2185084103 creator A5025372817 @default.
• W2185084103 creator A5027644811 @default.
• W2185084103 creator A5075286304 @default.
• W2185084103 creator A5079591035 @default.
• W2185084103 creator A5080372844 @default.
• W2185084103 creator A5087850879 @default.
• W2185084103 creator A5091722823 @default.
• W2185084103 date "2016-01-01" @default.
• W2185084103 modified "2023-09-25" @default.
• W2185084103 title "Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial" @default.
• W2185084103 cites W1975612181 @default.
• W2185084103 cites W1976853256 @default.
• W2185084103 cites W1977300462 @default.
• W2185084103 cites W2004649766 @default.
• W2185084103 cites W2013199731 @default.
• W2185084103 cites W2016107150 @default.
• W2185084103 cites W2018775194 @default.
• W2185084103 cites W2031267341 @default.
• W2185084103 cites W2033134239 @default.
• W2185084103 cites W2034038000 @default.
• W2185084103 cites W2037162426 @default.
• W2185084103 cites W2049018645 @default.
• W2185084103 cites W2053505239 @default.
• W2185084103 cites W2055057889 @default.
• W2185084103 cites W2059759023 @default.
• W2185084103 cites W2062458071 @default.
• W2185084103 cites W2084976122 @default.
• W2185084103 cites W2092708230 @default.
• W2185084103 cites W2093055978 @default.
• W2185084103 cites W2093928140 @default.
• W2185084103 cites W2099913957 @default.
• W2185084103 cites W2104563699 @default.
• W2185084103 cites W2113528184 @default.
• W2185084103 cites W2114046459 @default.
• W2185084103 cites W2133736841 @default.
• W2185084103 cites W2135215657 @default.
• W2185084103 cites W2138727947 @default.
• W2185084103 cites W2139182374 @default.
• W2185084103 cites W2139402015 @default.
• W2185084103 cites W2146708255 @default.
• W2185084103 cites W2169840817 @default.
• W2185084103 doi "https://doi.org/10.1016/j.jcv.2015.11.031" @default.
• W2185084103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26679830" @default.
• W2185084103 hasPublicationYear "2016" @default.
• W2185084103 type Work @default.
• W2185084103 sameAs 2185084103 @default.
• W2185084103 citedByCount "9" @default.
• W2185084103 countsByYear W21850841032016 @default.
• W2185084103 countsByYear W21850841032017 @default.
• W2185084103 countsByYear W21850841032018 @default.
• W2185084103 countsByYear W21850841032019 @default.
• W2185084103 countsByYear W21850841032020 @default.
• W2185084103 countsByYear W21850841032022 @default.
• W2185084103 crossrefType "journal-article" @default.
• W2185084103 hasAuthorship W2185084103A5008151489 @default.
• W2185084103 hasAuthorship W2185084103A5010104290 @default.
• W2185084103 hasAuthorship W2185084103A5018606311 @default.
• W2185084103 hasAuthorship W2185084103A5022216009 @default.
• W2185084103 hasAuthorship W2185084103A5025372817 @default.
• W2185084103 hasAuthorship W2185084103A5027644811 @default.
• W2185084103 hasAuthorship W2185084103A5075286304 @default.
• W2185084103 hasAuthorship W2185084103A5079591035 @default.
• W2185084103 hasAuthorship W2185084103A5080372844 @default.
• W2185084103 hasAuthorship W2185084103A5087850879 @default.
• W2185084103 hasAuthorship W2185084103A5091722823 @default.
• W2185084103 hasConcept C126322002 @default.
• W2185084103 hasConcept C159654299 @default.
• W2185084103 hasConcept C168563851 @default.
• W2185084103 hasConcept C203014093 @default.
• W2185084103 hasConcept C22070199 @default.
• W2185084103 hasConcept C2522874641 @default.
• W2185084103 hasConcept C2777382497 @default.
• W2185084103 hasConcept C2777410769 @default.
• W2185084103 hasConcept C2780593183 @default.
• W2185084103 hasConcept C2780791431 @default.
• W2185084103 hasConcept C2780801004 @default.
• W2185084103 hasConcept C2781037505 @default.
• W2185084103 hasConcept C71924100 @default.
• W2185084103 hasConcept C99454951 @default.
• W2185084103 hasConceptScore W2185084103C126322002 @default.
• W2185084103 hasConceptScore W2185084103C159654299 @default.
• W2185084103 hasConceptScore W2185084103C168563851 @default.
• W2185084103 hasConceptScore W2185084103C203014093 @default.
• W2185084103 hasConceptScore W2185084103C22070199 @default.
• W2185084103 hasConceptScore W2185084103C2522874641 @default.
• W2185084103 hasConceptScore W2185084103C2777382497 @default.
• W2185084103 hasConceptScore W2185084103C2777410769 @default.
• W2185084103 hasConceptScore W2185084103C2780593183 @default.
• W2185084103 hasConceptScore W2185084103C2780791431 @default.
• W2185084103 hasConceptScore W2185084103C2780801004 @default.
• W2185084103 hasConceptScore W2185084103C2781037505 @default.
• W2185084103 hasConceptScore W2185084103C71924100 @default.

• next